Efficient transduction of non-human primate motor neurons after intramuscular delivery of recombinant AAV serotype 6. (Q44852051)

6 December 2017

Efficient transduction of non-human primate motor neurons after intramuscular delivery of recombinant AAV serotype 6. (English)

1 reference

6 December 2017

2

1 reference

6 December 2017

C Towne

1

1 reference

6 December 2017

D Kieran

series ordinal

3

1 reference

6 December 2017

D E Redmond

series ordinal

4

1 reference

6 December 2017

P Aebischer

series ordinal

5

1 reference

6 December 2017

3 September 2009

1 reference

6 December 2017

1 reference

6 December 2017

17

1 reference

6 December 2017

1

1 reference

6 December 2017

141-146

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2009.119

6 December 2017

0 references

cites work

Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Effect on motor neuron survival in mutant SOD1 (G93A) transgenic mice by Bcl-2 expression using retrograde axonal transport of adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Gene therapy using adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal Muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Intramuscular viral delivery of paraplegin rescues peripheral axonopathy in a model of hereditary spastic paraplegia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Efficient Retrograde Neuronal Transduction Utilizing Self-complementary AAV1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Time course of transgene expression after intrastriatal pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 transduction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

7 January 2021

Efficient retrograde neuronal transduction utilizing self-complementary AAV1

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

7 January 2021

Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

7 January 2021

Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.119

7 January 2021

Identifiers

DOI

10.1038/GT.2009.119

1 reference

6 December 2017

1 reference